UPDATE
: Friday, December 13, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
AbbVie’s Venclexta nears insurance benefit
by Kim Eun-young
2019-12-06 16:35
Syntekabio, CHA Hospital to co-develop immunotherapy
by Lee Han-soo
2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs
by Lee Han-soo
2019-12-06 15:03
Petitioner demands broader benefit for ovarian cancer drug Zejula
by Song Soo-youn
2019-12-06 15:02
China OKs Humedix's hyaluronic acid filler
by Lee Han-soo
2019-12-06 15:02
라인
Foreign trainee doctors to get easier extension of training
by Kwak Sung-sun
2019-12-06 12:42
‘Endogenous T cells have high potential of treating blood, solid tumors’
by Lee Han-soo
2019-12-06 12:41
Korea exports health insurance system to Bahrain
by Kwak Sung-sun
2019-12-05 16:12
‘Lynparza raises value of precision medicine as anticancer treatment’
by Kim Yun-mi
2019-12-05 16:05
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
by Lee Han-soo
2019-12-05 15:04
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’
by Park Gi-taek
2019-12-05 13:01
Macrogen’s research on Asian genomic database becomes cover story of Nature
by Lee Han-soo
2019-12-05 11:54
‘Obesity treatment will drastically change next few years’
by Lee Han-soo
2019-12-04 18:20
'Insulin is safe, natural replacement therapy for diabetic patients'
by Lee Han-soo
2019-12-04 17:07
SK Biopharm set to ensure superiority in antiepileptic drug
by Jeong Sae-im
2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate
by Lee Han-soo
2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia
by Lee Han-soo
2019-12-04 16:16
Korean patient with rare breast cancer to sue Allergan in US
by Song Soo-youn
2019-12-04 14:49
Drugmakers strongly oppose post-approval evaluation
by Kim Eun-young
2019-12-04 13:17
Swedish researchers divide Type 2 diabetes into 5 subgroups
by Lee Han-soo
2019-12-03 17:45
-
1
2
3
4
5
6
7
8
9
10
다음
-
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
GC, Add Pharma to co-develop synthetic drugs
Helixmith to clarify why gene therapy study had data error
Daewoong releases trial results for autoimmune disease treatment candidate
Medical kiosks installed at major subway stations to help foreigners
여백
Most viewed
1
Aprogen, 1st Korean biotech firm to win unicorn status
2
Korea selected as 'Medical Tourism Destination of the Year'
3
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
4
ABL Bio unveils new bispecific antibody at US meet
5
AbbVie's releases new data for chronic lymphocytic leukemia treatment
6
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
7
Samsung execs get jail term for destroying evidence
8
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
9
Korean physician 1st Asian to do 1,000 robotic myomectomy surgeries
10
Samsung Bioepis to start P3 trial for Ontruzant in China
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top